COVID-19 and immune dysregulation: Genomic pathways, clinical manifestations, and therapeutic strategies
John Murphy, CEO & President, COVID-19 Long-haul Foundation Abstract SARS-CoV-2 provokes a uniquely heterogeneous and dynamic immune response that ranges from efficient viral control to fulminant hyperinflammation and prolonged immune…[...]
Read More